Pilot, open-label, single-arm clinical trial evaluating the efficacy of topical crisaborole for steroid refractory morphea

被引：3
|
作者：
Petty, Amy J. [1 ]
Emge, Drew A. [1 ]
Blanchard, Sarah K. [1 ]
Selim, Maria Angelica [2 ]
Scoggins, Kim [1 ]
Liu, Beiyu [3 ]
Green, Cynthia L. [3 ]
Cardones, Adela R. [4 ,5 ]
机构：
[1] Duke Univ, Dept Dermatol, Durham, NC USA
[2] Duke Univ, Dept Pathol, Div Dermatopathol, Durham, NC USA
[3] Duke Univ, Dept Biostat & Bioinformat, Sch Med, Durham, NC USA
[4] Univ Kansas, Med Ctr, Dept Internal Med, Div Dermatol, Kansas City, KS USA
[5] Univ Kansas, Med Ctr, Dept Internal Med, Div Dermatol, 3901 Rainbow Blvd, Kansas City, KS 66160 USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2023年 / 89卷 / 02期
关键词：
clinical trial; crisaborole; fibrosis; morphea; PDE4; CHILDREN; SAFETY;
D O I：
10.1016/j.jaad.2023.03.052
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
[No abstract available]
引用
收藏
页码：390 / 392
页数：3
相关论文
共 50 条
  • [21] Efficacy and Safety of Bavituximab in Combination with Sorafenib in Advanced Hepatocellular Carcinoma: A Single-Arm, Open-Label, Phase II Clinical Trial
    Mokdad, Ali A.
    Zhu, Hao
    Beg, Muhammad S.
    Arriaga, Yull
    Dowell, Jonathan E.
    Singal, Amit G.
    Yopp, Adam C.
    TARGETED ONCOLOGY, 2019, 14 (05) : 541 - 550
  • [22] Efficacy of glutathione for the treatment of nonalcoholic fatty liver disease: an open-label, single-arm, multicenter, pilot study
    Honda, Yasushi
    Kessoku, Takaomi
    Sumida, Yoshio
    Kobayashi, Takashi
    Kato, Takayuki
    Ogawa, Yuji
    Tomeno, Wataru
    Imajo, Kento
    Fujita, Koji
    Yoneda, Masato
    Kataoka, Koshi
    Taguri, Masataka
    Yamanaka, Takeharu
    Seko, Yuya
    Tanaka, Saiyu
    Saito, Satoru
    Ono, Masafumi
    Oeda, Satoshi
    Eguchi, Yuichiro
    Aoi, Wataru
    Sato, Kenji
    Itoh, Yoshito
    Nakajima, Atsushi
    BMC GASTROENTEROLOGY, 2017, 17
  • [23] Efficacy of glutathione for the treatment of nonalcoholic fatty liver disease: an open-label, single-arm, multicenter, pilot study
    Yasushi Honda
    Takaomi Kessoku
    Yoshio Sumida
    Takashi Kobayashi
    Takayuki Kato
    Yuji Ogawa
    Wataru Tomeno
    Kento Imajo
    Koji Fujita
    Masato Yoneda
    Koshi Kataoka
    Masataka Taguri
    Takeharu Yamanaka
    Yuya Seko
    Saiyu Tanaka
    Satoru Saito
    Masafumi Ono
    Satoshi Oeda
    Yuichiro Eguchi
    Wataru Aoi
    Kenji Sato
    Yoshito Itoh
    Atsushi Nakajima
    BMC Gastroenterology, 17
  • [24] EFFICACY AND SAFETY OF ADJUNCTIVE LURASIDONE IN TREATMENT RESISTANT UNIPOLAR DEPRESSION : AN OPEN-LABEL SINGLE-ARM PILOT STUDY
    Chiu, Nan-Ying
    Chang, Cheng-Ju
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2025, 28 : i324 - i325
  • [25] A Single-Arm, Open-Label, Phase IV Study to Evaluate the Efficacy of a Topical Formulation for Hyperkeratotic Actinic Keratosis Lesions
    Maria Pia De Padova
    Barbara Marzani
    Daniela Pinto
    Fabio Rinaldi
    Dermatology and Therapy, 2018, 8 : 455 - 462
  • [26] A Single-Arm, Open-Label, Phase IV Study to Evaluate the Efficacy of a Topical Formulation for Hyperkeratotic Actinic Keratosis Lesions
    De Padova, Maria Pia
    Marzani, Barbara
    Pinto, Daniela
    Rinaldi, Fabio
    DERMATOLOGY AND THERAPY, 2018, 8 (03) : 455 - 462
  • [27] A Multicenter, Open-Label, Single-Arm Trial of the Efficacy and Safety of Empagliflozin Treatment for Refractory Diabetes Mellitus with Insulin Resistance (EMPIRE-01)
    Hirota, Yushi
    Kakei, Yasumasa
    Imai, Junta
    Katagiri, Hideki
    Ebihara, Ken
    Wada, Jun
    Suzuki, Junichi
    Urakami, Tatsuhiko
    Omori, Takashi
    Ogawa, Wataru
    DIABETES THERAPY, 2024, 15 (02) : 533 - 545
  • [28] A Multicenter, Open-Label, Single-Arm Trial of the Efficacy and Safety of Empagliflozin Treatment for Refractory Diabetes Mellitus with Insulin Resistance (EMPIRE-01)
    Yushi Hirota
    Yasumasa Kakei
    Junta Imai
    Hideki Katagiri
    Ken Ebihara
    Jun Wada
    Junichi Suzuki
    Tatsuhiko Urakami
    Takashi Omori
    Wataru Ogawa
    Diabetes Therapy, 2024, 15 : 533 - 545
  • [29] Evaluating the Efficacy and Safety of Silodosin on Nocturia in Patients With Benign Prostatic Hyperplasia: A Multicenter, Prospective, Open-label, Single-arm, Phase IV Trial
    Cho, Kang Jun
    Lee, Jeong Zoo
    Song, Yun Seob
    Choi, Jong Bo
    Kim, Dae Kyung
    Kim, Yong Tae
    Kim, Joon Chul
    UROLOGY, 2018, 121 : 153 - 157
  • [30] Pembrolizumab in advanced osteosarcoma: results of a single-arm, open-label, phase 2 trial
    Kjetil Boye
    Alessandra Longhi
    Tormod Guren
    Susanne Lorenz
    Stine Næss
    Michela Pierini
    Ingeborg Taksdal
    Ingvild Lobmaier
    Marilena Cesari
    Anna Paioli
    Ayca M. Løndalen
    Elisabetta Setola
    Ivar Hompland
    Leonardo A. Meza-Zepeda
    Kirsten Sundby Hall
    Emanuela Palmerini
    Cancer Immunology, Immunotherapy, 2021, 70 : 2617 - 2624
12345